Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista JRG de Estudos Acadêmicos |
Texto Completo: | http://revistajrg.com/index.php/jrg/article/view/821 |
Resumo: | Endocardiosis, Myxomatous Mitral Valve Disease (MVD) is the disease that manifests itself most frequently in adult male dogs of small breeds. It is responsible for the development of Congestive Heart Failure (CHF), a chronic degenerative disease that negatively impacts the animal's quality of life and can lead to death. The study aimed to analyze and describe the possible treatment methods available for canine endocardiosis. The specific objectives involved the analysis of studies already carried out to identify the size and breeds most affected by the pathology; compare the evolution of the disease in the most affected breeds; review work already completed in the field of veterinary cardiology. The study reports the clinical case of a Schnauzer dog presenting clinical signs of congestive heart failure, such as cough, dyspnea, exercise intolerance and pulmonary edema. The complementary echocardiography exam showed Laminar Tricuspid Flow, Laminar Aortic Flow m/s and Laminar Pulmonary flow m/s, noting increased systolic diameter of the right ventricle, suggestive of systolic dysfunction; increased left ventricular diastolic diameter, suggestive of left ventricular congestion; left atrium with enlarged dimensions, suggestive of left atrial overload and mitral regurgitation reflux indicating severe mitral endocardiosis. Due to the advanced stage of the disease, intensive treatment was chosen using diuretics, vasodilators, positive inotropes and bronchodilators, to alleviate symptoms and improve the animal's quality of life. The treatment was administered for 48 days, resulting in death on December 14, 2022. |
id |
JRG_93c8bb68cb27bbea994c2dc8b40933ac |
---|---|
oai_identifier_str |
oai:ojs2.revistajrg.com:article/821 |
network_acronym_str |
JRG |
network_name_str |
Revista JRG de Estudos Acadêmicos |
repository_id_str |
|
spelling |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case reportEficácia do tratamento medicamentoso na endocardiose de valva mitral em cães idosos: relato de casoEndocardioseCão adultoTratamentoEndocardiosisAdult dogTreatmentEndocardiosis, Myxomatous Mitral Valve Disease (MVD) is the disease that manifests itself most frequently in adult male dogs of small breeds. It is responsible for the development of Congestive Heart Failure (CHF), a chronic degenerative disease that negatively impacts the animal's quality of life and can lead to death. The study aimed to analyze and describe the possible treatment methods available for canine endocardiosis. The specific objectives involved the analysis of studies already carried out to identify the size and breeds most affected by the pathology; compare the evolution of the disease in the most affected breeds; review work already completed in the field of veterinary cardiology. The study reports the clinical case of a Schnauzer dog presenting clinical signs of congestive heart failure, such as cough, dyspnea, exercise intolerance and pulmonary edema. The complementary echocardiography exam showed Laminar Tricuspid Flow, Laminar Aortic Flow m/s and Laminar Pulmonary flow m/s, noting increased systolic diameter of the right ventricle, suggestive of systolic dysfunction; increased left ventricular diastolic diameter, suggestive of left ventricular congestion; left atrium with enlarged dimensions, suggestive of left atrial overload and mitral regurgitation reflux indicating severe mitral endocardiosis. Due to the advanced stage of the disease, intensive treatment was chosen using diuretics, vasodilators, positive inotropes and bronchodilators, to alleviate symptoms and improve the animal's quality of life. The treatment was administered for 48 days, resulting in death on December 14, 2022. A Endocardiose, Doença Mixomatosa da Valvas Mitral (DMVM) é a enfermidade que se manifesta com maior frequência em cães machos, adultos de raças pequena. É responsável pelo desenvolvimento da Insuficiência Cardíaca Congestiva (ICC), doença crônica degenerativa que impacta de forma negativa na qualidade de vida do animal, podendo levá-lo a morte. O estudo teve como objetivo analisar e descrever os possíveis métodos de tratamento disponíveis para Endocardiose canina. Os objetivos específicos envolveram a análise de estudos já realizados para identificar o porte e as raças mais acometidas pela patologia; comparar a evolução da doença nas raças mais acometidas; revisar trabalhos já concluídos no âmbito de cardiologia veterinária e relatar o caso clínico de um cão da raça Schnauzer apresentando sinais clínicos de insuficiência cardíaca congestiva, como tosse, dispneia, intolerância ao exercício e edema pulmonar. O exame complementar de ecocardiografia o apresentou Fluxo Tricuspídeo Laminar, Fluxo Aórtico Laminar m/s e fluxo Pulmonar Laminar m/s, constatando-se: aumento do diâmetro sistólico do ventrículo direito, sugestivo de disfunção sistólica; aumento do diâmetro diastólico do ventrículo esquerdo, sugestivo de congestão do ventrículo esquerdo; átrio esquerdo com dimensões aumentadas, sugestivo de sobrecarga atrial esquerda e refluxo de regurgitação mitral indicando endocardiose de mitral severa. Devido ao estágio avançado da doença optou-se pelo tratamento intensivo com uso de diuréticos, vasodilatadores, inotrópicos positivos e broncodilatadores, para aliviar os sintomas e melhorar a qualidade de vida do animal. O tratamento foi ministrado durante 48 dias, resultando em óbito no dia 14 de dezembro de 2022.Editora JRG2023-12-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigo avaliado pelos Paresapplication/pdfhttp://revistajrg.com/index.php/jrg/article/view/82110.55892/jrg.v6i13.821ark:/57118/JRG.v6i13.821JRG Journal of Academic Studies; Vol. 6 No. 13 (2023): JRG Journal of Academic Studies; 2346-2359JRG Journal of Academic Studies ; Vol. 6 Núm. 13 (2023): Revista JRG de Estudos Acadêmicos; 2346-2359JRG Journal of Academic Studies; V. 6 N. 13 (2023): Revista JRG de Estudos Acadêmicos; 2346-2359Revista JRG de Estudos Acadêmicos ; v. 6 n. 13 (2023): Revista JRG de Estudos Acadêmicos; 2346-23592595-1661ark:/57118/jrg.v6i13reponame:Revista JRG de Estudos Acadêmicosinstname:Editora JRGinstacron:JRGporhttp://revistajrg.com/index.php/jrg/article/view/821/771https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAmado, Alexia da Silva DutraClasta, Ricardo Birolini2023-11-29T13:28:26Zoai:ojs2.revistajrg.com:article/821Revistahttp://revistajrg.com/index.php/jrgPRIhttp://revistajrg.com/index.php/jrg/oaiprofessorjonas@gmail.com||2595-16612595-1661opendoar:2023-11-29T13:28:26Revista JRG de Estudos Acadêmicos - Editora JRGfalse |
dc.title.none.fl_str_mv |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report Eficácia do tratamento medicamentoso na endocardiose de valva mitral em cães idosos: relato de caso |
title |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report |
spellingShingle |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report Amado, Alexia da Silva Dutra Endocardiose Cão adulto Tratamento Endocardiosis Adult dog Treatment |
title_short |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report |
title_full |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report |
title_fullStr |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report |
title_full_unstemmed |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report |
title_sort |
Efficacy of drug treatment in mitral valve endocardiosis in elderly dogs: case report |
author |
Amado, Alexia da Silva Dutra |
author_facet |
Amado, Alexia da Silva Dutra Clasta, Ricardo Birolini |
author_role |
author |
author2 |
Clasta, Ricardo Birolini |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Amado, Alexia da Silva Dutra Clasta, Ricardo Birolini |
dc.subject.por.fl_str_mv |
Endocardiose Cão adulto Tratamento Endocardiosis Adult dog Treatment |
topic |
Endocardiose Cão adulto Tratamento Endocardiosis Adult dog Treatment |
description |
Endocardiosis, Myxomatous Mitral Valve Disease (MVD) is the disease that manifests itself most frequently in adult male dogs of small breeds. It is responsible for the development of Congestive Heart Failure (CHF), a chronic degenerative disease that negatively impacts the animal's quality of life and can lead to death. The study aimed to analyze and describe the possible treatment methods available for canine endocardiosis. The specific objectives involved the analysis of studies already carried out to identify the size and breeds most affected by the pathology; compare the evolution of the disease in the most affected breeds; review work already completed in the field of veterinary cardiology. The study reports the clinical case of a Schnauzer dog presenting clinical signs of congestive heart failure, such as cough, dyspnea, exercise intolerance and pulmonary edema. The complementary echocardiography exam showed Laminar Tricuspid Flow, Laminar Aortic Flow m/s and Laminar Pulmonary flow m/s, noting increased systolic diameter of the right ventricle, suggestive of systolic dysfunction; increased left ventricular diastolic diameter, suggestive of left ventricular congestion; left atrium with enlarged dimensions, suggestive of left atrial overload and mitral regurgitation reflux indicating severe mitral endocardiosis. Due to the advanced stage of the disease, intensive treatment was chosen using diuretics, vasodilators, positive inotropes and bronchodilators, to alleviate symptoms and improve the animal's quality of life. The treatment was administered for 48 days, resulting in death on December 14, 2022. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-12-06 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigo avaliado pelos Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://revistajrg.com/index.php/jrg/article/view/821 10.55892/jrg.v6i13.821 ark:/57118/JRG.v6i13.821 |
url |
http://revistajrg.com/index.php/jrg/article/view/821 |
identifier_str_mv |
10.55892/jrg.v6i13.821 ark:/57118/JRG.v6i13.821 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
http://revistajrg.com/index.php/jrg/article/view/821/771 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Editora JRG |
publisher.none.fl_str_mv |
Editora JRG |
dc.source.none.fl_str_mv |
JRG Journal of Academic Studies; Vol. 6 No. 13 (2023): JRG Journal of Academic Studies; 2346-2359 JRG Journal of Academic Studies ; Vol. 6 Núm. 13 (2023): Revista JRG de Estudos Acadêmicos; 2346-2359 JRG Journal of Academic Studies; V. 6 N. 13 (2023): Revista JRG de Estudos Acadêmicos; 2346-2359 Revista JRG de Estudos Acadêmicos ; v. 6 n. 13 (2023): Revista JRG de Estudos Acadêmicos; 2346-2359 2595-1661 ark:/57118/jrg.v6i13 reponame:Revista JRG de Estudos Acadêmicos instname:Editora JRG instacron:JRG |
instname_str |
Editora JRG |
instacron_str |
JRG |
institution |
JRG |
reponame_str |
Revista JRG de Estudos Acadêmicos |
collection |
Revista JRG de Estudos Acadêmicos |
repository.name.fl_str_mv |
Revista JRG de Estudos Acadêmicos - Editora JRG |
repository.mail.fl_str_mv |
professorjonas@gmail.com|| |
_version_ |
1797068982722756608 |